Sort
82,697 grants matching “vaccine development”
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
$1,190,331Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2017 · AI
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES
$1,190,313Rustom Noshir Antia · Emory University · U01 · FY2021 · AI
Metabolic and Immunologic Effects of Meditation
$1,190,220Frederick M Hecht · University Of California, San Francisco · P01 · FY2010 · AT
Biomarker Investigations for Clinical Trials
$1,189,791Kerstin Heselmeyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA
$1,189,723University Of California San Francisco · R01 · FY2002 · CA
St. Jude/Memphis IMPAACT Clinical Trials Unit (Composite)
$1,189,565Patricia Michele Flynn · St. Jude Children'S Research Hospital · UM1 · FY2012 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,189,451University Of Alabama At Birmingham · U01 · FY2001 · AI
Computational models of naturally acquired immunity to falciparum malaria
$1,189,438Bryan R Greenhouse · University Of California, San Francisco · U01 · FY2022 · AI
Multiscale Analysis of Immune Responses
$1,189,401Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Biochemical and structural mechanisms at the filoviral-host interface
$1,189,295Gaya K. Amarasinghe · Washington University · P01 · FY2024 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$1,189,190Daniel F. Hoft · Saint Louis University · UM1 · FY2024 · AI
University of Rochester HIV/AIDS Clinical Trials Unit
$1,189,150Michael C Keefer · University Of Rochester · UM1 · FY2016 · AI
Science in a Culture of Mentoring
$1,189,027Judith A James · Oklahoma Medical Research Foundation · P30 · FY2010 · RR
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,188,978Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
$1,188,896Priyamvada Acharya · Duke University · U54 · FY2023 · AI
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,188,642Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Complete Analysis of T cell Epitopes from Yellow Fever Virus
$1,188,598Soren Buus · University Of Copenhagen · N01 · FY2011 · AI
Medical Scientist Training Program
$1,188,535Christopher S. Williams · Vanderbilt University · T32 · FY2018 · GM
Innate inflammatory responses during pulmonary infections
$1,188,232Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,187,646Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Spirulina oral supplement for enhancing host resilience to virus infection
$1,187,562Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2022 · AT
Computational biology scientific research support component
$1,187,428Thomas B Kepler · Duke University · UM1 · FY2017 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,187,399Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Structural Biology of Influenza Epitopes
$1,186,925Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Development of an anti-malaria toxin vaccine candidate
$1,186,750William J Christ · Ancora Pharmaceuticals, Inc. · R44 · FY2007 · AI